Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. GGHCX: which is better?

Bottom line

FHLC vs GGHCX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 54% by weight.

But FHLC is far broader, holding 337 positions to 82 for GGHCX, so beyond the top names it adds exposure GGHCX doesn't have.

FHLC is cheaper at 0.084% vs 1.07% — a difference of $99 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +2.6% for GGHCX (reporting dates differ).

GGHCX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

FHLC vs GGHCX side by side

FHLCGGHCX
TypeETFMutual fund
Fund familyFidelityInvesco
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%1.07%
Annual cost per $10k$8.4$107
10-yr cost on $10k (prospectus)$108$1,784
Max front loadNone5.5%
12b-1 fee0%0.25%
1-yr return+2.6%+9.2%
5-yr return (annualized)+7.2%+2.6%
10-yr return (annualized)+8.8%+5.8%
Best quarter+16.4%+19.6%
Worst quarter−13.1%−16.5%
Net assets (fund)$3.3B$1.2B
Number of holdings33782
Portfolio turnover3%59%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCGGHCXDifference
2024+2.6%+4.0%−1.4%
2023+2.5%+3.1%−0.6%
2022−5.5%−13.5%+8.1%
2021+20.4%+12.2%+8.2%
2020+18.1%+14.5%+3.7%
2019+21.9%+32.0%−10.1%
2018+5.5%+0.5%+5.1%
2017+23.3%+15.5%+7.9%
2016−3.3%−11.7%+8.4%

Source: Fund prospectus bar charts

Holdings overlap

10 of FHLC's top 25 holdings also appear in GGHCX's top 25.

Shared top holdings
HoldingFHLCGGHCX
Eli Lilly & Co13.35%10.59%
Johnson & Johnson8.93%6.76%
AbbVie Inc6.42%4.03%
UnitedHealth Group Inc5.44%6.17%
Merck & Co Inc4.66%4.59%
Thermo Fisher Scientific Inc3.09%1.55%
Gilead Sciences Inc2.34%3.63%
CVS Health Corp1.92%2.52%
Vertex Pharmaceuticals Inc1.76%2.01%
Cardinal Health Inc0.78%2.10%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

GGHCX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

FAQ

What is the difference between FHLC and GGHCX?
FHLC (Fidelity MSCI Health Care Index ETF) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 54% by weight. But FHLC is far broader, holding 337 positions to 82 for GGHCX, so beyond the top names it adds exposure GGHCX doesn't have.
Which is cheaper, FHLC or GGHCX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and GGHCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.